A randomized trial of weekly cardiotocography in high-risk obstetric patients

Br J Obstet Gynaecol. 1983 Nov;90(11):1018-26. doi: 10.1111/j.1471-0528.1983.tb06439.x.

Abstract

A randomized clinical trial of once-weekly antenatal fetal heart rate monitoring in 539 high-risk patients could find no benefit of monitoring in terms of perinatal mortality, morbidity or Apgar score. The previously well-documented association between abnormal antenatal fetal heart rate traces and low Apgar score was confirmed. A detailed case review showed that in this population monitoring was irrelevant to almost all of the 13 perinatal deaths.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Apgar Score
  • Birth Weight
  • Clinical Trials as Topic
  • Female
  • Fetal Heart / physiology*
  • Fetal Monitoring*
  • Heart Rate*
  • Humans
  • Infant Mortality
  • Infant, Newborn
  • Middle Aged
  • Pregnancy
  • Random Allocation
  • Risk